BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37506875)

  • 1. Varenicline enhances recognition memory via α7 nicotinic acetylcholine receptors in the medial prefrontal cortex in male mice.
    Esaki H; Deyama S; Izumi S; Katsura A; Nishikawa K; Nishitani N; Kaneda K
    Neuropharmacology; 2023 Nov; 239():109672. PubMed ID: 37506875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotine Enhances Object Recognition Memory via Stimulating α4β2 and α7 Nicotinic Acetylcholine Receptors in the Medial Prefrontal Cortex of Mice.
    Esaki H; Izumi S; Fukao A; Ito S; Nishitani N; Deyama S; Kaneda K
    Biol Pharm Bull; 2021; 44(7):1007-1013. PubMed ID: 34193682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procognitive effects of varenicline in the animal model of schizophrenia depend on α4β2- and α 7-nicotinic acetylcholine receptors.
    Potasiewicz A; Golebiowska J; Popik P; Nikiforuk A
    J Psychopharmacol; 2018 Dec; 33(1):269881118812097. PubMed ID: 30501536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prefrontal beta2 subunit-containing and alpha7 nicotinic acetylcholine receptors differentially control glutamatergic and cholinergic signaling.
    Parikh V; Ji J; Decker MW; Sarter M
    J Neurosci; 2010 Mar; 30(9):3518-30. PubMed ID: 20203212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of medial prefrontal cortex voltage-dependent potassium 4.3 channels in nicotine-induced enhancement of object recognition memory in male mice.
    Esaki H; Izumi S; Nishikawa K; Nagayasu K; Kaneko S; Nishitani N; Deyama S; Kaneda K
    Eur J Pharmacol; 2024 Jun; ():176790. PubMed ID: 38942263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine Enhances Firing Activity of Layer 5 Pyramidal Neurons in the Medial Prefrontal Cortex through Inhibition of Kv7 Channels.
    Izumi S; Domoto M; Esaki H; Sasase H; Nishitani N; Deyama S; Kaneda K
    Biol Pharm Bull; 2021; 44(5):724-731. PubMed ID: 33952828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate dopamine release in vitro and in vivo in the rat prefrontal cortex.
    Livingstone PD; Srinivasan J; Kew JN; Dawson LA; Gotti C; Moretti M; Shoaib M; Wonnacott S
    Eur J Neurosci; 2009 Feb; 29(3):539-50. PubMed ID: 19187266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varenicline improves cognitive impairment in a mouse model of mPFC ischemia: The possible roles of inflammation, apoptosis, and synaptic factors.
    Seyedaghamiri F; Hosseini L; Kazmi S; Mahmoudi J; Shanehbandi D; Ebrahimi-Kalan A; Rahbarghazi R; Sadigh-Eteghad S; Farhoudi M
    Brain Res Bull; 2022 Apr; 181():36-45. PubMed ID: 35066097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel α7 nicotinic acetylcholine receptor agonist EVP-6124 enhances dopamine, acetylcholine, and glutamate efflux in rat cortex and nucleus accumbens.
    Huang M; Felix AR; Flood DG; Bhuvaneswaran C; Hilt D; Koenig G; Meltzer HY
    Psychopharmacology (Berl); 2014 Dec; 231(23):4541-51. PubMed ID: 24810107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of varenicline on alpha4-containing nicotinic acetylcholine receptor expression and cognitive performance in mice.
    Lange-Asschenfeldt C; Schäble S; Suvorava T; Fahimi EG; Bisha M; Stermann T; Henning U; Kojda G
    Neuropharmacology; 2016 Aug; 107():100-110. PubMed ID: 27012889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of attentional performance by selective stimulation of alpha4beta2(*) nAChRs: underlying cholinergic mechanisms.
    Howe WM; Ji J; Parikh V; Williams S; Mocaër E; Trocmé-Thibierge C; Sarter M
    Neuropsychopharmacology; 2010 May; 35(6):1391-401. PubMed ID: 20147893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel alpha7 nicotinic acetylcholine receptor agonist N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide improves working and recognition memory in rodents.
    Boess FG; De Vry J; Erb C; Flessner T; Hendrix M; Luithle J; Methfessel C; Riedl B; Schnizler K; van der Staay FJ; van Kampen M; Wiese WB; Koenig G
    J Pharmacol Exp Ther; 2007 May; 321(2):716-25. PubMed ID: 17308038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of alpha4beta2 nicotinic receptors in rats.
    Spiller K; Xi ZX; Li X; Ashby CR; Callahan PM; Tehim A; Gardner EL
    Neuropharmacology; 2009 Jul; 57(1):60-6. PubMed ID: 19393252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of ethanol consumption by genetic and pharmacological manipulation of nicotinic acetylcholine receptors in mice.
    Kamens HM; Andersen J; Picciotto MR
    Psychopharmacology (Berl); 2010 Mar; 208(4):613-26. PubMed ID: 20072781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors.
    Prickaerts J; van Goethem NP; Chesworth R; Shapiro G; Boess FG; Methfessel C; Reneerkens OA; Flood DG; Hilt D; Gawryl M; Bertrand S; Bertrand D; König G
    Neuropharmacology; 2012 Feb; 62(2):1099-110. PubMed ID: 22085888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights on the effects of varenicline on nicotine reward, withdrawal and hyperalgesia in mice.
    Bagdas D; Alkhlaif Y; Jackson A; Carroll FI; Ditre JW; Damaj MI
    Neuropharmacology; 2018 Aug; 138():72-79. PubMed ID: 29860196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The smoking cessation drug varenicline improves deficient P20-N40 inhibition in DBA/2 mice.
    Wildeboer-Andrud KM; Stevens KE
    Pharmacol Biochem Behav; 2011 Nov; 100(1):17-24. PubMed ID: 21763340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α7 nicotinic acetylcholine receptors in the medial prefrontal cortex control rewarding but not aversive memory expression in a dopamine-sensitive manner.
    Pastor V; Dalto JF; Medina JH
    Pharmacol Biochem Behav; 2023 Jun; 227-228():173594. PubMed ID: 37385456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varenicline blocks β2*-nAChR-mediated response and activates β4*-nAChR-mediated responses in mice in vivo.
    Ortiz NC; O'Neill HC; Marks MJ; Grady SR
    Nicotine Tob Res; 2012 Jun; 14(6):711-9. PubMed ID: 22241831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The selective alpha7 nicotinic acetylcholine receptor agonist A-582941 activates immediate early genes in limbic regions of the forebrain: Differential effects in the juvenile and adult rat.
    Thomsen MS; Mikkelsen JD; Timmermann DB; Peters D; Hay-Schmidt A; Martens H; Hansen HH
    Neuroscience; 2008 Jun; 154(2):741-53. PubMed ID: 18495359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.